Clinical Trial Update: Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of combining Simeprevir with Sofosbuvir in adults with chronic hepatitis C without cirrhosis; results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Olysio (Simeprevir)
• Sovaldi (Sofosbuvir)

Snippet

Sponsor: Janssen Infectious Diseases BVBA | Conditions: Hepatitis C Virus Infection | Phase 3 | Status: COMPLETED | Results posted: 2016-04-12